Publication Shows Telomir-Zn Restores Vision in Retinal Disease Model
Telomir Pharmaceuticals announced peer-reviewed research demonstrating Telomir-Zn's ability to improve visual function and restore retinal structure in an AMD model. The findings validate the company's epigenetic mechanism of action and suggest broader applications beyond cancer.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed